Related Experiment Video
Updated: Dec 27, 2025

Perturbations of Circulating miRNAs in Irritable Bowel Syndrome Detected Using a Multiplexed High-throughput Gene Expression Platform
Published on: November 30, 2016
From IBS to ME - The dysbiotic march hypothesis
Arnold Berstad1, Olav Hauso2, Ketil Berstad3
1University of Bergen, Norway.
Irritable bowel syndrome (IBS) may progress to chronic fatigue syndrome (CFS), fibromyalgia, and myalgic encephalopathy (ME) through a "dysbiotic march." Early antibiotic use in childhood may initiate this progression, leading to later systemic symptoms.
Area of Science:
- Gastroenterology and Immunology
- Microbiome Research
- Chronic Illness Pathogenesis
Background:
- Irritable bowel syndrome (IBS) frequently co-occurs with chronic fatigue syndrome (CFS), fibromyalgia, and myalgic encephalopathy (ME).
- The underlying mechanisms linking these conditions remain largely unknown.
- Intestinal dysbiosis is a potential common factor.
Purpose of the Study:
- To propose a novel hypothesis for the progression of IBS to systemic conditions like ME.
- To introduce the concept of a
- dysbiotic march
- analogous to the
- atopic march
- in allergic diseases.
- To explore the potential role of early-life antibiotic exposure in initiating this march.
Main Methods:
- Analysis of data from 1100 consecutive IBS patients over nine years.
- Observational study examining disease progression patterns.
- Hypothesis formulation based on clinical observations.
Main Results:
- A hypothesized sequential development from IBS to ME, termed the
- dysbiotic march
- .
- Early childhood antibiotic exposure identified as a potential trigger.
- Abdominal complaints like IBS may precede systemic symptoms such as CFS, fibromyalgia, and ME by several years.
Conclusions:
- The
- dysbiotic march
- hypothesis offers a potential explanation for the link between IBS and subsequent systemic illnesses.
- Early antibiotic use may disrupt the gut microbiome, initiating a cascade towards chronic disease.
- Further research is warranted to validate the
- dysbiotic march
- and its implications for managing IBS and related conditions.
More Related Videos
Related Concept Videos
Irritable Bowel Syndrome I: Introduction
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome III: Medical and Nursing Management
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...

